November 18, 2021
  • The Biden administration released an interim final rule that will require health insurers and employers to report a plethora of drug data to the federal government. Insurers would need to disclose the 50 most expensive drugs they cover and the 25 drugs that yield the highest rebates from drug manufacturers. Collecting all of this data will allow federal researchers to understand trends in drug pricing, which continues to have a big impact on people’s wallets and health insurance premiums. (Press release here; Rule here)